Ensure Safe Use of Sulfonylureas for Type 2 Diabetes

Patients will continue to be admitted on sulfonylureas despite all the hype and TV ads about newer drugs for type 2 diabetes.

The spotlight has been on empagliflozin (Jardiance), canagliflozin (Invokana), and liraglutide (Victoza) as options to add to metformin...since they reduce CV risk in certain diabetes patients.

And some clinicians are wondering if sulfonylureas should still be considered...since they can cause hypoglycemia and weight gain.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals